NeuroPrecision decodes how your child’s genes impact medication, so doctors can treat autism, ADHD, anxiety, and depression faster, with less guesswork.
Physicians and parents can order a NeuroPrecision test online and receive a comprehensive AI-powered pharmacogenomic report within three weeks. An integrated AI Co-Pilot supports clinicians in interpreting the results and identifying the most effective treatment plan for each patient.
Other Genetics Tests
NeuroPrecision analyzes over 350 genes and 800 variants tied to medication response, giving clinicians a deeper view than standard tests. Its AI-powered co-pilot interprets results and guides providers to faster, more precise treatment decisions for neurodevelopmental and mental health conditions.
Fewer missteps, lower costs, and more confident care.
NeuroPrecision delivers advanced pharmacogenomic insights at a fraction of the typical cost. By combining comprehensive gene coverage with AI-driven analysis, it makes personalized treatment more accessible without compromising clinical depth or quality.
With analysis of over 350 genes and 800 drug-related variants, NeuroPrecision goes far beyond industry standards (<30 genes). This expansive scope unlocks therapeutic options previously unavailable, particularly for complex neurodevelopmental and psychiatric conditions.
Each report is generated using AI trained on clinical trials and real-world outcomes, then delivered with built-in Co-Pilot support. Physicians receive not just data, but actionable insights, making it easier to select the most effective medication from the start.
From test to report in under three weeks, NeuroPrecision accelerates decision-making when time matters most. Faster insights mean earlier interventions, reduced trial and error, and more timely relief for patients and families.
If trial-and-error isn’t good enough for your child, you’re in the right place!
